Get instant access to our resource bundle and learn how others are using Mitra® devices with VAMS® technology and remote specimen collection to study SARS-CoV-2, influenza, and other infectious diseases, and the drugs that treat them.Download Now
Our Infectious Disease Resource Bundle will help you easily adopt a new, remote approach to sample collection that enables research studies and clinical trials to occur at-home, in the field, or in locations without clinically trained staff. Mitra® devices with VAMS® technology provide simple precision for remote microsampling and efficient, automated lab processing. Learn how the National Institutes of Health (NIH), Swiss Tropical Institute, LGC Group, and other organizations are deploying remote microsampling with Mitra® devices globally.
Source/Credit: NIBIB/NIH. Nature Communications. Volume 12, Article number: 113 (2021)
Mitra® remote microsampling devices are extremely well-suited for both small and large-scale serology studies. Research provided in our resource bundle illustrates:
Access our Resource Bundle for all these details plus insight into a multiplex assay that uses Mitra devices to simultaneously measure >30 strains of influenza.
Credit: Christopher Barnes and Pamela Bjorkman, California Institute of Technology, Pasadena.
Accurate measurement of antibody levels is critical for understanding both natural and vaccine-induced immunity. Antibody and immunity studies will inform "immunity passports," facilitating a return to school, work, and other activities. These studies benefit from remote microsampling. Mitra microsamples are quantitative and precise (RSD < 4%), enabling the reporting of specific titer levels. Data within our resource bundle shows:
Read all about this data and more in our Infectious Disease Research Resource Bundle and access the relevant literature for more insights.
Source/Credit: Quanterix. https://doi.org/10.1101/2020.08.14.20175356
Antigen detection is commonly performed using a nasal and/or throat swab. This specimen collection method can be extremely uncomfortable, and can result in a high number of false negatives. Quanterix conducted research in an effort to expand the specimen collection and testing options available, recently publishing a their study paper in Nature Communications demonstrating:
This paper, included in our Resource Bundle, suggests that both antibody and antigen detection can be conducted from one Mitra device using the same instrument platform for a more comprehensive study of infectious diseases.
Mitra® remote specimen collection delivers tremendous value in clinical trials, including accelerated recruitment, increased diversity, and improved retention. Researchers at leading pharmaceutical / biopharmaceutical organizations are using Mitra devices to:
Download our Resource Bundle to dig into the details regarding the above. The bundle gives you access to lessons learned from conducting internet-based randomized clinical trials during a global pandemic, and other insights.
Credit: DropBio Pty Ltd (data provided as a courtesy prior to publication)
Researchers investigate cytokines and other biomarkers as early predictors of severe Covid-19 illness. They are hopeful at the prospect of earlier identification and intervention of patients at high risk for severe Covid-19 and other infections. Data included in our Resource Bundle illustrates that the following is possible with Mitra devices:
Learn more by reading our news articles, including the one titled, cytokines as predictive biomarkers of severe COVID-19: could at-home sampling be helpful?
Collecting biological specimens in low-resource areas to study tropical diseases is difficult and expensive. Mitra devices offer a convenient, reliable, and cost-effective solution to these issues. Mitra devices with VAMS tips also overcome the drying and analytical bias issues encountered with dried blood spot cards. Leading research institutions specializing in tropical medicine prefer Mitra collection for a variety of research projects, such as:
Read our Infectious Disease Resource Bundle for additional insights on how to implement remote MItra microsampling in tropical medicine.
As the Coronavirus Pandemic spread around the globe in 2020, we saw accelerated adoption of Mitra® devices and VAMS® technology for remote microsampling studies. With entire countries in lockdown, researchers realized it was time to fully embrace remote studies, decentralized trials, and virtual models. You can offer remote specimen collection to help people avoid exposure to contagions while they contribute to science.
Leaders in infectious disease research use microsampling in innovative ways, from remote vaccine studies to drug trials for effective therapies.
Mitra devices with VAMS technology deliver on the promise of microsampling with simplicity and precision ... Start your volumetric microsampling study today!
Safer, Simpler, Smarter, and More Convenient.